Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)₂D, but No Difference in Ratio of 25(OH)D/24,25(OH)₂D and FGF23 Concentrations

by Mariska C Vlot, Laura Boekel, Jolijn Kragt, Joep Killestein, Barbara M. van Amerongen, Robert de Jonge, Martin den Heijer, Annemieke C. Heijboer
Published 2019-11-01